{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:04:30Z","timestamp":1790319870598,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejcancer.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ejca.2013.12.022","type":"journal-article","created":{"date-parts":[[2014,1,28]],"date-time":"2014-01-28T01:15:45Z","timestamp":1390871745000},"page":"1065-1075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Chemoradiotherapy, with adjuvant surgery for local control, confers a durable survival advantage in adenocarcinoma and squamous cell carcinoma of the oesophagus"],"prefix":"10.1016","volume":"50","author":[{"given":"G.A.","family":"Bass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Furlong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.E.","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.P.J.","family":"Hennessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.N.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejca.2013.12.022_b0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/JTO.0b013e3182397751","article-title":"Temporal trends in long-term survival and cure rates in oesophageal cancer: a SEER database analysis","volume":"7","author":"Dubecz","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2013.12.022_b0010","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1245\/s10434-006-9333-0","article-title":"Better survival in patients with oesophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologists","volume":"14","author":"Verhoef","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2013.12.022_b0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/bjs.1800820133","article-title":"Early oesophageal cancer: results of a European multicentre survey. Group Europ\u00e9en pour l\u2019Etude des Maladies de l\u2019Oesophage","volume":"82","author":"Bonavina","year":"1995","journal-title":"Br J Surg"},{"issue":"10","key":"10.1016\/j.ejca.2013.12.022_b0020","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/gutjnl-2012-302412","article-title":"A global assessment of the oesophageal adenocarcinoma epidemic","volume":"62","author":"Edgren","year":"2013","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ejca.2013.12.022_b0025","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ijrobp.2008.08.046","article-title":"Patterns of care and locoregional treatment outcomes in older oesophageal cancer patients: The SEER-Medicare Cohort","volume":"74","author":"Smith","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejca.2013.12.022_b0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/CEJ.0b013e328341e2f6","article-title":"Oesophageal cancer risk among immigrants in Sweden","volume":"20","author":"Mousavi","year":"2011","journal-title":"Eur J Cancer Prev"},{"issue":"2","key":"10.1016\/j.ejca.2013.12.022_b0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2168.2001.01655.x","article-title":"One-year survey of carcinoma of the oesophagus and stomach in Wales","volume":"88","author":"Pye","year":"2001","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.ejca.2013.12.022_b0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.soc.2009.09.007","article-title":"Randomized clinical trials in oesophageal carcinoma","volume":"19","author":"Barnett","year":"2010","journal-title":"Surg Oncol Clin N Am"},{"issue":"22","key":"10.1016\/j.ejca.2013.12.022_b0045","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for oesophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ejca.2013.12.022_b0050","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/jso.21566","article-title":"Advances in the surgical treatment of oesophageal cancer","volume":"101","author":"Ng","year":"2010","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2013.12.022_b0055","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0002-9610(02)00795-X","article-title":"A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable oesophageal cancer","volume":"183","author":"Urschel","year":"2002","journal-title":"Am J Surg"},{"issue":"7","key":"10.1016\/j.ejca.2013.12.022_b0060","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/gut.2003.025080","article-title":"Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis","volume":"53","author":"Fiorica","year":"2004","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ejca.2013.12.022_b0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ctrv.2003.11.009","article-title":"Pre-operative chemo-radiotherapy improves 3-year survival in people with resectable oesophageal cancer","volume":"30","author":"Naughton","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejca.2013.12.022_b0070","first-page":"CD001556","article-title":"Preoperative chemotherapy for resectable thoracic oesophageal cancer","volume":"3","author":"Malthaner","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ejca.2013.12.022_b0075","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1470-2045(07)70039-6","article-title":"Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis","volume":"8","author":"Gebski","year":"2007","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2013.12.022_b0080","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(05)70288-6","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial","volume":"6","author":"Burmeister","year":"2005","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2013.12.022_b0085","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/annonc\/mdh219","article-title":"A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable oesophageal squamous cell carcinoma","volume":"15","author":"Lee","year":"2004","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2013.12.022_b0090","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.2001.19.2.305","article-title":"Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional oesophageal carcinoma","volume":"19","author":"Urba","year":"2001","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2013.12.022_b0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199707173370304","article-title":"Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the oesophagus","volume":"337","author":"Bosset","year":"1997","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejca.2013.12.022_b0100","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJM199608153350702","article-title":"A comparison of multimodal therapy and surgery for oesophageal adenocarcinoma","volume":"335","author":"Walsh","year":"1996","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejca.2013.12.022_b0105","first-page":"391","article-title":"A prospective study of combined therapy in oesophageal cancer","volume":"41","author":"Apinop","year":"1994","journal-title":"Hepatogastroenterology"},{"issue":"7","key":"10.1016\/j.ejca.2013.12.022_b0110","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/1097-0142(19940401)73:7<1779::AID-CNCR2820730702>3.0.CO;2-T","article-title":"A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the oesophagus","volume":"73","author":"Le Prise","year":"1994","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2013.12.022_b0115","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/BF02067069","article-title":"Pre-operative radiotherapy prolongs survival in operable oesophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in oesophageal cancer","volume":"16","author":"Nygaard","year":"1992","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.ejca.2013.12.022_b0120","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9610(03)00066-7","article-title":"A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable oesophageal cancer","volume":"185","author":"Urschel","year":"2003","journal-title":"Am J Surg"},{"issue":"2","key":"10.1016\/j.ejca.2013.12.022_b0125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.surg.2004.06.033","article-title":"Neoadjuvant chemoradiotherapy for oesophageal carcinoma: a meta-analysis","volume":"137","author":"Greer","year":"2005","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.ejca.2013.12.022_b0130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1072-7515(02)01221-8","article-title":"Controversies in the current therapy of carcinoma of the oesophagus","volume":"195","author":"Blom","year":"2002","journal-title":"J Am Coll Surg"},{"issue":"3","key":"10.1016\/j.ejca.2013.12.022_b0135","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0002-9610(03)00222-8","article-title":"Is neoadjuvant therapy the answer to adenocarcinoma of the oesophagus?","volume":"186","author":"Burak","year":"2003","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.ejca.2013.12.022_b0140","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM199701303360512","article-title":"Multimodal therapy for oesophageal adenocarcinoma","volume":"336","author":"Badwe","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejca.2013.12.022_b0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1442-2050.2002.00214.x","article-title":"Neoadjuvant treatment of advanced stage oesophageal adenocarcinoma increases survival","volume":"15","author":"Walsh","year":"2002","journal-title":"Dis Oesophagus"},{"issue":"7","key":"10.1016\/j.ejca.2013.12.022_b0150","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for oesophageal cancer: CALGB 9781","volume":"26","author":"Tepper","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.12.022_b0155","doi-asserted-by":"crossref","unstructured":"Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. Multimodality treatment plus surgery versus surgery alone for oesophageal squamous cell carcinoma; 1996.","DOI":"10.1016\/0016-5085(95)26515-5"},{"key":"10.1016\/j.ejca.2013.12.022_b0160","unstructured":"AJCC cancer staging manual. Oesophagus. In: American Joint Committee on Cancer. 6th ed. New York: Springer; 2002."},{"issue":"2","key":"10.1016\/j.ejca.2013.12.022_b0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/sim.4780010204","article-title":"Tables of the number of patients required in clinical trials using the logrank test","volume":"1","author":"Freedman","year":"1982","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.ejca.2013.12.022_b0170","first-page":"A611","article-title":"Multimodality therapy versus surgery for oesophageal adenocarcinoma. A prospective randomised trial","volume":"110","author":"Walsh","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2013.12.022_b0175","first-page":"CD00544","article-title":"Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults","volume":"8","author":"Gluud","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.ejca.2013.12.022_b0180","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00268-003-7063-z","article-title":"Current status of neoadjuvant therapy for adenocarcinoma of the distal oesophagus","volume":"27","author":"Zacherl","year":"2003","journal-title":"World J Surg"},{"issue":"12","key":"10.1016\/j.ejca.2013.12.022_b0185","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nrc2933","article-title":"Does tumour dormancy offer a therapeutic target?","volume":"10","author":"Goss","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2013.12.022_b0190","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","article-title":"Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma","volume":"18","author":"Landreville","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ejca.2013.12.022_b0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"Longley","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2013.12.022_b0200","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/1471-2407-11-438","article-title":"Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival","volume":"11","author":"Birgisson","year":"2011","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2013.12.022_b0205","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1078-0432.CCR-03-1077","article-title":"Competing causes of death and second primary tumours in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy","volume":"10","author":"Argiris","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.ejca.2013.12.022_b0210","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00535-006-1835-9","article-title":"Promise of definitive chemoradiotherapy for oesophageal cancer balanced with late radiation toxicity: an old but new issue","volume":"41","author":"Hyodo","year":"2006","journal-title":"J Gastroenterol"},{"issue":"5","key":"10.1016\/j.ejca.2013.12.022_b0215","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00535-006-1771-8","article-title":"Late toxicity in complete response cases after definitive chemoradiotherapy for oesophageal squamous cell carcinoma","volume":"41","author":"Kumekawa","year":"2006","journal-title":"J Gastroenterol"},{"issue":"14","key":"10.1016\/j.ejca.2013.12.022_b0220","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1200\/JCO.2003.03.055","article-title":"Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic oesophagus","volume":"21","author":"Ishikura","year":"2003","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2013.12.022_b0225","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ejso.2004.06.009","article-title":"Surgery alone in the curative treatment of localised oesophageal carcinoma","volume":"30","author":"Mariette","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2013.12.022_b0230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2482-8-21","article-title":"Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the oesophagus (CROSS)","volume":"8","author":"van Heijl","year":"2008","journal-title":"BMC Surg"},{"issue":"2","key":"10.1016\/j.ejca.2013.12.022_b0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jgo.2012.12.006","article-title":"Tailoring therapy for oesophageal cancer in patients aged 70 and over","volume":"4","author":"Furlong","year":"2013","journal-title":"J Geriatric Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2013.12.022_b0240","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jamcollsurg.2005.12.022","article-title":"Modern 5-year survival of resectable oesophageal adenocarcinoma: single institution experience with 263 patients","volume":"202","author":"Portale","year":"2006","journal-title":"J Am Coll Surg"},{"issue":"6","key":"10.1016\/j.ejca.2013.12.022_b0245","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/SLA.0b013e3181904f3c","article-title":"Predicting systemic disease in patients with oesophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes","volume":"248","author":"Peyre","year":"2008","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.ejca.2013.12.022_b0250","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1007\/s00268-009-0223-z","article-title":"Neoadjuvant chemoradiotherapy for oesophageal cancer: a review of meta-analyses","volume":"33","author":"Wijnhoven","year":"2009","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.ejca.2013.12.022_b0255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/030089161209800108","article-title":"Clinical study of concurrent chemoradiotherapy or radiotherapy alone for oesophageal cancer patients with positive lymph node metastasis","volume":"98","author":"Han","year":"2012","journal-title":"Tumouri"},{"issue":"4","key":"10.1016\/j.ejca.2013.12.022_b0260","first-page":"299","article-title":"Oesophageal cancer: biology, natural history, staging and therapeutic options","volume":"98","author":"Mortensen","year":"2007","journal-title":"Minerva Med"},{"issue":"12","key":"10.1016\/j.ejca.2013.12.022_b0265","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/JTO.0b013e31815bfe53","article-title":"Prognostic factors after combined modality treatment of squamous cell carcinoma of the oesophagus","volume":"2","author":"Rizk","year":"2007","journal-title":"J Thorac Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804914000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804914000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T02:34:49Z","timestamp":1565145289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804914000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0959804914000045"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2013.12.022","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemoradiotherapy, with adjuvant surgery for local control, confers a durable survival advantage in adenocarcinoma and squamous cell carcinoma of the oesophagus","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2013.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}